Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network.


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
03 2019
Historique:
received: 24 07 2018
revised: 07 11 2018
accepted: 12 11 2018
pubmed: 18 11 2018
medline: 20 2 2020
entrez: 17 11 2018
Statut: ppublish

Résumé

Macrometastases in bone are preceded by bone marrow invasion of disseminated tumor cells. This study combined functional imaging parameters from FDG-PET/CT and MRI in a rat model of breast cancer bone metastases to a Model-averaged Neural Network (avNNet) for the detection of early metastatic disease and prediction of future macrometastases. Metastases were induced in 28 rats by injecting MDA-MB-231 breast cancer cells into the right superficial epigastric artery, resulting in the growth of osseous metastases in the right hind leg of the animals. All animals received FDG-PET/CT and MRI at days 0, 10, 20 and 30 after tumor cell injection. In total, 18/28 rats presented with metastases at days 20 or 30 (64.3%). None of the animals featured morphologic bone lesions during imaging at day 10, and the imaging parameters acquired at day 10 did not differ significantly between animals with metastases at or after day 20 and those without (all p > 0.3). The avNNet trained with the imaging parameters acquired at day 10, however, achieved an accuracy of 85.7% (95% CI 67.3-96.0%) in predicting future macrometastatic disease (ROC

Identifiants

pubmed: 30445200
pii: S8756-3282(18)30429-0
doi: 10.1016/j.bone.2018.11.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-261

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Stephan Ellmann (S)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: stephan.ellmann@uk-erlangen.de.

Lisa Seyler (L)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: lisa.seyler@uk-erlangen.de.

Jochen Evers (J)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Henrik Heinen (H)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Aline Bozec (A)

Department of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: aline.bozec@uk-erlangen.de.

Olaf Prante (O)

Department of Nuclear Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: olaf.prante@uk-erlangen.de.

Torsten Kuwert (T)

Department of Nuclear Medicine, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: torsten.kuwert@uk-erlangen.de.

Michael Uder (M)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: michael.uder@uk-erlangen.de.

Tobias Bäuerle (T)

Department of Radiology, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Electronic address: tobias.baeuerle@uk-erlangen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH